Лечение ЗППП
5. Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17:110-2.
6. Richardson BA. Nonoxynol-9 as a vaginal mircrobicide for prevention of sexually transmitted infections. JAMA 2002:287:1171-2.
7. Gates W, Stone KM. Family planning, sexually transmitted diseases, and contraceptive choice: a literature update—part 1. Farn Plann Perspectives 1992:24:74-84.
8. CDC. Revised guidelines for HIV counseling, testing, ana referral and revised recommendations for HIV screening of pregnant women. MMWR200l:50(No. RR-19): 13-26.
9. Kamb ML, Fishbein M, Douglas JM, et al. Н1У prevention counseling reduces high risk behaviors and sexually transmitted diseases'. results from a multicenter, randomized controlled trial (Project RESPECT). JAMA 1998:280:1161-7.
10. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore, MD: Williams & Wilkins, 1996.
11. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 4th ed. Washington. DC: American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 1997.
12. American College of Obstetricians and Gynecologists. Antimic robial therapy for obstetric patients. Washington, DC: American College of Obstetricians and Gynecologists, March 1998. (Educational bulletin, no. 245.)
13. American College of Obstetricians and Gvnecologists. Committee opin- ion: primary and preventive care. Washington. DC: American College of Obstetricians find Gyneci/iogist\, December 1999. (Penodic assessments, no. 229.)
14. CDC. Recommendations for the prevention and management of Chlamydiatrachomatis infections. 1993. MMWR. 1993;42(No. RR-12).
15. Zanetti AR, Tanzi E, Ne\\ell ML. Mother-to- in/am transmission .hepatitis С virus. J Hepatol 1999:3! (Suppl):96-l 00.
16. Burns DN, Minkoff H. Hepatitis C: screening in pregnancy Obsiel Gynecol 1999:94:1044.
17. American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists, July 1998. (Educational bulletin, no. 248.)
18. American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Human immunodeficiency virus screening' joint statement of the AAP and AGOG. Pediatrics 1999:104:128.
19. Institute of Medicine. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press, 1999.
20. CDC. Revised US Public Health Service recommendations for human immunodeficiency virus screening of pregnant women. MMWR2001;50(No. RR-I9):59-86.
21. CDC. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 2001 USPHS/JDSA guidelines for the prevention of opportunistic infections in persons infected wth human immunodeficiency virus. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, November 28, 2001. Available al http://www.hivatis.org.
22. CDC. Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR (in press).
23. Department of Health and Human Services, H"nry J. Kaiser Foundation Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. US Department of Health and Human Services, February 4, 2002. Available at hitp./Avvr'w.hivatis.org.
24. Carpenter CJ. Cooper DA, Fi^cbi ЫА, et u\. An'tire'lroviral therapy т adults updated recommendations of the International AIDS Society- " USA Panel JAMA 2000,283 381-90
25. CDC CDC National Prevention Plan Federal Register 2002 (in press)
26. CDC Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus principles of therapy and revised recommendations MMWR 1998 47 (No RR-20)
27. CDC HIV Prevention case management guidance Atlanta GA US Department of Health and Human Services, Public Health Service, September 1997
28. Fowler MG, Simonds RJ, Roongpisuthipong A Update on perinatal HIV transmission Pediatr Clin North Am 2000,47 241-60
29. CDC Recommendations for the ше of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States Atlanta, GA US Department of Health and Human Services, February' 4 2002 Available at http //wwwhivatis org
30. CDC Guidelines for the use of'antiretroviral agents in pediatnc HIV infection Atlanta, GA US Department of Health and Human Services, August 8, 2001 Available at http ffwww hivatis org
31. Wald A New therapies and prevention strategies for genital herpes Clin Infect Dis 1999.28(Suppl) S4-S13
32. Bodsworth NJ, Crooks RJ, Borelli S, et al Valaciclovir versus acyclovir in patient-initiated treatment of genital herpes a randomized, double-blind clinical trial Gemtounn Med 1997 73 110-6
33. Patel R, Bodsworth NJ, Wooley P, et al Valaciclovir for the suppression of recurrent genital HSV infection a placebo controlled study of once-daily therapy Gemtounn Med 1997,73 105-9
34. Spruance S, Trying S, Degregono В, Miller С, Beutner К, the Valaciclovir HSV Study Group A large-scale, placebo-controlled, dose-ranging trial ofperoral valacyclovirfor episodic treatment of recurrent herpes genitalis Arch Int Med 1996,156 1729-35
35. Fife КН. Barbarash RA, Rudolph Т, Degregono В, Roth RE Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection results of an international, multicenter, double-blind randomized clinical trial Sex Transm Dis 1997,24 481-6
36. Reitano M, Tyring S, bang W, et al Valaciclovirfor the suppression of recurrent genital herpes simplex virus infection a large-scale dose range-finding study J Infect Dis 1998 178 603-10
37. Chosidow0, Drouault Y, Lecontae- Veynac F, et al Famciclo\ir vs aciclovir in immunocompetent patients with recurrent genital herpes infections a parallel-groups, randomized, double-blind clinical trial Br J Dermatol 2001 144 818-24
38. Diaz-Mitoma F. Sibbald RG, Shafran SD, Boon R, Saltzman RL Oral famciclovir for the suppression of recurrent genital herpes a randomized controlled trial JAMA 1998,280887-92
39. Loveless M, Harris W, Sacks S Treatment of first episode genital herpes with famciclovir In Programs and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, 1995
40. Mertz GJ, Loveless МО, Levin MJ et al Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women a multicenter, double-blind, placebo-controlled trial Arch Intern Med 1997.157 343-9
41. Sacks SL. Aoki FY, Diaz-Mitoma F. Sellers J Shafran SD Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes a randomized, double-blind multicenter trial JAMA 1996 276 44-9
